These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27173004)

  • 1. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.
    Lillico R; Stesco N; Khorshid Amhad T; Cortes C; Namaka MP; Lakowski TM
    Future Med Chem; 2016 May; 8(8):879-97. PubMed ID: 27173004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting LSD1 in cancer: Molecular elucidation and recent advances.
    Cai W; Xiao C; Fan T; Deng Z; Wang D; Liu Y; Li C; He J
    Cancer Lett; 2024 Aug; 598():217093. PubMed ID: 38969160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadmium induces histone H3 lysine methylation by inhibiting histone demethylase activity.
    Xiao C; Liu Y; Xie C; Tu W; Xia Y; Costa M; Zhou X
    Toxicol Sci; 2015 May; 145(1):80-9. PubMed ID: 25673502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine-14 acetylation of histone H3 in chromatin confers resistance to the deacetylase and demethylase activities of an epigenetic silencing complex.
    Wu M; Hayward D; Kalin JH; Song Y; Schwabe JW; Cole PA
    Elife; 2018 Jun; 7():. PubMed ID: 29869982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical probes for histone-modifying enzymes.
    Cole PA
    Nat Chem Biol; 2008 Oct; 4(10):590-7. PubMed ID: 18800048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the impact of gene variants on histone lysine methylation.
    Van Rechem C; Whetstine JR
    Biochim Biophys Acta; 2014 Dec; 1839(12):1463-76. PubMed ID: 24859469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate deficiency affects histone methylation.
    Garcia BA; Luka Z; Loukachevitch LV; Bhanu NV; Wagner C
    Med Hypotheses; 2016 Mar; 88():63-7. PubMed ID: 26880641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors.
    Culhane JC; Wang D; Yen PM; Cole PA
    J Am Chem Soc; 2010 Mar; 132(9):3164-76. PubMed ID: 20148560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures.
    Nowotarski SL; Pachaiyappan B; Holshouser SL; Kutz CJ; Li Y; Huang Y; Sharma SK; Casero RA; Woster PM
    Bioorg Med Chem; 2015 Apr; 23(7):1601-12. PubMed ID: 25725609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the development of activity-based probes for detection of lysine-specific demethylase-1 activity.
    Ourailidou ME; Lenoci A; Zwergel C; Rotili D; Mai A; Dekker FJ
    Bioorg Med Chem; 2017 Feb; 25(3):847-856. PubMed ID: 27989416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural simulation and selective inhibitor discovery study for histone demethylases KDM4E/6B from a computational perspective.
    Wang C; Hu B; Yang Y; Wang Y; Qin J; Wen X; Li Y; Li H; Wang Y; Wang J; Liu Y
    Comput Biol Chem; 2024 Jun; 110():108072. PubMed ID: 38636391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Drugs of Lysine Specific Histone Demethylase-1 (LSD1) Display Variable Inhibition on Nucleosome Substrates.
    Senanayaka D; Zeng D; Deniz E; Priyankara IK; Helmbreck J; Schneider O; Mardikar A; Uren A; Reiter NJ
    Biochemistry; 2024 Jun; 63(11):1369-1375. PubMed ID: 38742921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controllers of histone methylation-modifying enzymes in gastrointestinal cancers.
    Li L; Song Q; Zhou J; Ji Q
    Biomed Pharmacother; 2024 May; 174():116488. PubMed ID: 38520871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Inhibitors as Alzheimer's Disease Therapeutic Agents.
    Yamashita Y; Itoh Y; Takada Y; Suzuki T
    Chem Pharm Bull (Tokyo); 2024; 72(7):630-637. PubMed ID: 38945939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors.
    Quinn AM; Allali-Hassani A; Vedadi M; Simeonov A
    Mol Biosyst; 2010 May; 6(5):782-8. PubMed ID: 20567762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of histone demethylases in cancers.
    Tong D; Tang Y; Zhong P
    Cancer Metastasis Rev; 2024 Jun; 43(2):795-821. PubMed ID: 38227150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.
    Gerken PA; Wolstenhulme JR; Tumber A; Hatch SB; Zhang Y; Müller S; Chandler SA; Mair B; Li F; Nijman SMB; Konietzny R; Szommer T; Yapp C; Fedorov O; Benesch JLP; Vedadi M; Kessler BM; Kawamura A; Brennan PE; Smith MD
    Angew Chem Int Ed Engl; 2017 Dec; 56(49):15555-15559. PubMed ID: 28976073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM1 class flavin-dependent protein lysine demethylases.
    Burg JM; Link JE; Morgan BS; Heller FJ; Hargrove AE; McCafferty DG
    Biopolymers; 2015 Jul; 104(4):213-46. PubMed ID: 25787087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based development of novel substrate-type G9a inhibitors as epigenetic modulators for sickle cell disease treatment.
    Nishigaya Y; Takase S; Sumiya T; Sato T; Niwa H; Sato S; Nakata A; Matsuoka S; Maemoto Y; Hashimoto N; Namie R; Honma T; Umehara T; Shirouzu M; Koyama H; Yoshida M; Ito A; Shirai F
    Bioorg Med Chem Lett; 2024 Sep; 110():129856. PubMed ID: 38914346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis.
    Wigle TJ; Provencher LM; Norris JL; Jin J; Brown PJ; Frye SV; Janzen WP
    Chem Biol; 2010 Jul; 17(7):695-704. PubMed ID: 20659682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.